United States Pharmacopeia online
Select Pharmacopoeia
Anhydrous Lactose
Add the following:
Attribute JP EP USP
Definition + + +
Clarity and color of solution + + +
Specific rotation + + +
Acidity or alkalinity + + +
Loss on drying + +
Water + + +
Content of alpha and beta anomers + + +
Residue on ignition + + +
Protein and light-absorbing impurities + + +
Legend: + will adopt and implement; – will not stipulate.
Nonharmonized attributes: Characters, Labeling, Microbial limits, Heavy metals, Packaging and storage, Identification (IR).
Specific local attributes: Identification B and C (USP), Particle size distribution (USP), Particle size distribution EP (FRC).
Click to View Image
Change to read:
» Anhydrous Lactose is O--d-galactopyranosyl-(1®4)--d-glucopyranose (-lactose) or a mixture of O--d-galactopyranosyl-(1®4)--d-glucopyranose and O--d-galactopyranosyl-(1®4)--d-glucopyranose (-lactose).NF26
Add the following:
Packaging and storage— Preserve in tight containers.NF26
Change to read:
Labeling— Where the labeling indicates the relative quantities of alpha and beta lactose, determine compliance using Content of alpha and beta anomers. Where the labeling states the particle size distribution, it also indicates the d10, d50, and d90 values and the range for each.NF26
Add the following:
Clarity and color of solution— A solution of 1 g in 10 mL of boiling water is clear and nearly colorless. Determine the absorbance of this solution at a wavelength of 400 nm. The absorbance divided by the path length, in cm, is not more than 0.04.NF26
Identification—
B: Proceed as directed in Identification test B under Lactose Monohydrate, except to use USP Anhydrous Lactose RS instead of USP Lactose Monohydrate RS in Standard solution A and B and to use Anhydrous Lactose in the Test solution.
C: Proceed as directed in Identification test C under Lactose Monohydrate.
Add the following:
Specific rotation 781 Dissolve 10 g by heating in 80 mL of water to 50. Allow to cool, and add 0.2 mL of 6 N ammonium hydroxide. Allow to stand for 30 minutes, and dilute with water to 100 mL: the specific rotation, calculated on the anhydrous basis, determined at 20, is between +54.4 and +55.9.NF26
Add the following:
Microbial limits 61 The total aerobic microbial count does not exceed 100 cfu per g, the total combined molds and yeasts count does not exceed 50 cfu per g, and it meets the requirements of the test for absence of Escherichia coli.NF26
Add the following:
Acidity or alkalinity— Dissolve 6 g by heating in 25 mL of carbon dioxide-free water, cool, and add 0.3 mL of phenolphthalein TS: the solution is colorless, and not more than 0.4 mL of 0.1 N sodium hydroxide is required to produce a red color.NF26
Loss on drying 731 Dry it at 80 for 2 hours: it loses not more than 0.5% of its weight.
Water, Method I 921: not more than 1.0%, determined on a preparation containing anhydrous lactose in a mixture of methanol and formamide (2:1).
Add the following:
Residue on ignition 281: not more than 0.1%, determined on a specimen ignited at a temperature of 600 ± 50.NF26
Add the following:
Protein and light-absorbing impurities 851 Measure the light absorption of a 1% (w/v) solution in the range of 210 nm to 300 nm. The absorbance divided by the path length, in cm, is not more than 0.25 in the range of 210 nm to 220 nm and is not more than 0.07 in the range of 270 nm to 300 nm.NF26
Content of alpha and beta anomers—
Silylation reagent— Prepare a mixture of pyridine and trimethylsilylimidazole (72:28).
Resolution mixture— Prepare a mixture of alpha lactose monohydrate and beta lactose having an anomeric ratio of about 1:1 based on the labeled anomeric contents of the alpha lactose monohydrate and the beta lactose.
Chromatographic system (see Chromatography 621)—The gas chromatograph is equipped with a flame-ionization detector and a 4-mm × 0.9-m glass column packed with 3% liquid phase G19 on support S1A. The column temperature is maintained at about 215, and the injection port and the detector temperatures are maintained at about 275. The carrier gas is helium, flowing at a rate of about 40 mL per minute.
Derivatization procedure— Transfer about 1 mg of Anhydrous Lactose to a 5-mL reaction vial equipped with a screw cap, add 0.45 mL of dimethyl sulfoxide, seal the vial tightly with a screw cap, and mix on a vortex mixer to dissolve. Add 1.8 mL of Silylation reagent, seal the vial tightly with a screw cap, and mix gently. Transfer about 1 mg of Resolution mixture to a second 5-mL reaction vial equipped with a screw cap, add 0.45 mL of dimethyl sulfoxide, seal the vial tightly with a screw cap, and mix on a vortex mixer to dissolve. Add 1.8 mL of Silylation reagent, seal the vial tightly with a screw cap, and mix gently. Maintain both vials at room temperature for 20 minutes before using.
Procedure— Inject a 2.0-µL portion of the derivatized Resolution mixture into the chromatograph, and record the peak areas for the major peaks: the relative retention times are about 0.7 for the silyl derivative of alpha lactose and 1.0 for the silyl derivative of beta lactose, and the resolution, R, between the two peaks is not less than 3.0. Similarly inject a 2.0-µL portion of the derivatized Anhydrous Lactose into the chromatograph, and record the peak areas for the major peaks. Determine the percentage of alpha anomer in the Anhydrous Lactose by the formula:
100ra / (ra + rb)
in which ra is the response of the alpha anomer silyl derivative peak and rb is the response of the beta anomer silyl derivative peak. Determine the percentage of beta anomer in the Anhydrous Lactose by the formula:
100rb / (ra + rb)
in which the terms are as defined above.
Delete the following:
Other requirements— It meets the requirements for Packaging and storage, Labeling, Clarity and color of solution, Specific rotation 781, Microbial limits 61, Acidity or alkalinity, Residue on ignition 281, and Protein and light-absorbing impurities under Lactose Monohydrate.NF26
Auxiliary Information— Staff Liaison : Kevin T. Moore, Ph.D., Scientist
Expert Committee : (EM105) Excipient Monographs 1
USP31–NF26 Page 1159
Pharmacopeial Forum : Volume No. 32(6) Page 1847
Phone Number : 1-301-816-8369